Dyskinesia News and Research

RSS
New treatment shows promise in easing symptoms of Parkinson's disease

New treatment shows promise in easing symptoms of Parkinson's disease

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

First randomized, controlled trial of pharmacotherapy in PCD patients now in place

First randomized, controlled trial of pharmacotherapy in PCD patients now in place

Enrollment completed in Pharma Two B's P2B001 Phase IIb study for Parkinson's disease treatment

Enrollment completed in Pharma Two B's P2B001 Phase IIb study for Parkinson's disease treatment

NeuroPerspective features comprehensive reviews of schizophrenia, spinal cord injury

NeuroPerspective features comprehensive reviews of schizophrenia, spinal cord injury

Study: Levodopa-carbidopa intestinal gel improves quality of life in advanced PD patients

Study: Levodopa-carbidopa intestinal gel improves quality of life in advanced PD patients

Researchers close to novel therapy to treat levodopa-induced dyskinesia

Researchers close to novel therapy to treat levodopa-induced dyskinesia

Young Researcher's Meeting on Primary Ciliary Dyskinesia to be held in Bern, Switzerland

Young Researcher's Meeting on Primary Ciliary Dyskinesia to be held in Bern, Switzerland

FDA approves RYTARY for Parkinson's disease treatment

FDA approves RYTARY for Parkinson's disease treatment

Brandeis University researchers capture highest resolution images of cilia ever

Brandeis University researchers capture highest resolution images of cilia ever

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Levodopa dose linked to malnutrition risk in Parkinson’s disease

Levodopa dose linked to malnutrition risk in Parkinson’s disease

Zebrafish may hold key to unlocking a leading cause of respiratory diseases

Zebrafish may hold key to unlocking a leading cause of respiratory diseases

Research to help patients suffering from severe spinal cord injuries

Research to help patients suffering from severe spinal cord injuries

Study: Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Study: Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Sleep problems in PD patients can worsen in later stages of disease

Sleep problems in PD patients can worsen in later stages of disease

Low accuracy of clinical diagnosis for early Parkinson’s disease

Low accuracy of clinical diagnosis for early Parkinson’s disease

Little efficacy difference between old and new antipsychotics

Little efficacy difference between old and new antipsychotics

Presynaptic dopaminergic lesion predicts drug-induced dyskinesia

Presynaptic dopaminergic lesion predicts drug-induced dyskinesia

Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease